UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?

Annals of oncology, 2012-03, Vol.23 (3), p.714-721

2012

Volltextzugriff (PDF)

CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database

Breast (Edinburgh), 2020-02, Vol.49, p.17-24

2020

Volltextzugriff (PDF)

1581 Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: A multicentric observational national French study in patients with solid tumors (The Zohé study)

European journal of cancer (1990), 2015-09, Vol.51, p.S231-S232

2015

Volltextzugriff (PDF)

Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial

Contemporary clinical trials communications, 2020-03, Vol.17, p.100536-100536, Article 100536

2020

Volltextzugriff (PDF)

7051 POSTER Bicalutamide in Combination With Vandetanib or Placebo in Patients With Castration-refractory Metastatic Prostate Cancer Without Any Clinical Symptom Related to Disease Progression – a Randomized, Double-blind Phase II Trial

European journal of cancer (1990), 2011, Vol.47, p.S500-S500

2011

Volltextzugriff (PDF)

5159 POSTER A Randomized Study Comparing Standard to Response-adapted Sequence in HER2 Negative Operable Breast Cancer

European journal of cancer (1990), 2011, Vol.47, p.S377-S377

2011

Volltextzugriff (PDF)

7045 POSTER Docetaxel and Curcuminoids Combination in Patients With Hormone Resistant Prostate Cancer – a Phase II Study

European journal of cancer (1990), 2011, Vol.47, p.S498-S498

2011

Volltextzugriff (PDF)

Corrigendum to “De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): characteristics and prognosis” [Eur J Cancer 158 (2021) 181–188]

European journal of cancer (1990), 2022-05, Vol.166, p.311-312

2022

Volltextzugriff (PDF)

De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis

European journal of cancer (1990), 2021-11, Vol.158, p.181-188

2021

Volltextzugriff (PDF)

Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial

Annals of oncology, 2014-05, Vol.25 (5), p.987-991

2014

Volltextzugriff (PDF)

Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases

European journal of cancer (1990), 2017-12, Vol.87, p.140-146

2017

Volltextzugriff (PDF)

Basal/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial

Annals of oncology, 2024-09

2024

Volltextzugriff (PDF)

AVENANCE : efficacité et tolérance en vie réelle d’avelumab en traitement d’entretien de première ligne (1LM) chez les patients atteints d’un carcinome urothélial avancé (aUC) et analyse exploratoire des traitements subséquents

Progrès en urologie. Formation médicale continue, 2024-11, Vol.34 (7), p.S64-S65

2024

Volltextzugriff (PDF)

Doxorubicin and Ifosfamide in Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Phase II Study of the Genitourinary Group of the French Federation of Cancer Centers

The Journal of urology, 2002-09, Vol.168 (3), p.959-961

2002

Volltextzugriff (PDF)

Anti?aromatases San Antonio 2003 : chronique d?une mort annonc e pour le tamoxif ne?

Oncologie (Paris, France), 2004-05, Vol.6 (3)

Eymard, J.C.

2004

Volltextzugriff (PDF)

Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

European journal of cancer (1990), 2001-06, Vol.37 (9), p.1132-1140

2001

Volltextzugriff (PDF)

Phase I/II trial of autologous activated macrophages in advanced colorectal cancer

European journal of cancer (1990), 1996-10, Vol.32 (11), p.1905-1911

1996

Volltextzugriff (PDF)

311 PAIN AND PSA RESPONSES IN METASTATIC HORMONE REFRACTORY PROSTATE CANCER TREATED WITH SATRAPLATIN: RESULTS OF THE SPARC PHASE III TRIAL

European urology supplements : official journal of the European Association of Urology, 2007, Vol.6 (2), p.100-100

2007

Volltextzugriff (PDF)

Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation

British journal of cancer, 2023-06, Vol.128 (11), p.2072-2080

2023

Volltextzugriff (PDF)

306P Real-life management and prognosis of young women (≤ 40 yo) with de novo metastatic breast cancer in the multicenter national observational ESME program

Annals of oncology, 2020-09, Vol.31, p.S365-S365

2020

Volltextzugriff (PDF)

P.14.11 Auto-immune necrotizing myopathies with anti-HMGCR antibodies are related to statin-exposure only for a minority of cases

Neuromuscular disorders : NMD, 2013-10, Vol.23 (9), p.816-817

2013

Volltextzugriff (PDF)

P2.49 Myopathies with mutations in anoctamin 5: Phenotype and gene mutations in a French cohort

Neuromuscular disorders : NMD, 2011-10, Vol.21 (9), p.675-675

2011

Volltextzugriff (PDF)

On the stability of colocated clustered finite volume simplicial discretizations for the 2D Stokes problem

Calcolo, 2007-12, Vol.44 (4), p.219-234

2007

Volltextzugriff (PDF)

Late-onset rod myopathy associated with monoclonal gammopathy

Neuromuscular disorders : NMD, 1993-01, Vol.3 (5), p.557-560

1993

Volltextzugriff (PDF)

Inhibiting Effect of Vitamins C and B12 on the Mitotic Activity of Ascites Tumors

Pathobiology (Basel), 1979, Vol.47 (3), p.210-217

1979

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(26)

Sprache

Englisch
(24)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(12)
Humans
(8)
Oncology
(8)
Female
(7)
Adult
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Biological And Medical Sciences
(5)
Male
(5)
Medical Sciences
(5)
Middle Aged
(5)
Aged
(4)
Chemotherapy
(4)
Hematology, Oncology And Palliative Medicine
(4)
Prognosis
(4)
Treatment Outcome
(4)
Tumors
(4)
Antineoplastic Agents
(3)
Breast Cancer
(3)
Cancer
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?

CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database

1581 Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: A multicentric observational national French study in patients with solid tumors (The Zohé study)

7051 POSTER Bicalutamide in Combination With Vandetanib or Placebo in Patients With Castration-refractory Metastatic Prostate Cancer Without Any Clinical Symptom Related to Disease Progression – a Randomized, Double-blind Phase II Trial

5159 POSTER A Randomized Study Comparing Standard to Response-adapted Sequence in HER2 Negative Operable Breast Cancer

7045 POSTER Docetaxel and Curcuminoids Combination in Patients With Hormone Resistant Prostate Cancer – a Phase II Study

Corrigendum to “De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): characteristics and prognosis” [Eur J Cancer 158 (2021) 181–188]

De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis

Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial

Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases

Basal/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial

AVENANCE : efficacité et tolérance en vie réelle d’avelumab en traitement d’entretien de première ligne (1LM) chez les patients atteints d’un carcinome urothélial avancé (aUC) et analyse exploratoire des traitements subséquents

Doxorubicin and Ifosfamide in Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Phase II Study of the Genitourinary Group of the French Federation of Cancer Centers

Anti?aromatases San Antonio 2003 : chronique d?une mort annonc e pour le tamoxif ne?

Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

Phase I/II trial of autologous activated macrophages in advanced colorectal cancer

311 PAIN AND PSA RESPONSES IN METASTATIC HORMONE REFRACTORY PROSTATE CANCER TREATED WITH SATRAPLATIN: RESULTS OF THE SPARC PHASE III TRIAL

Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation

306P Real-life management and prognosis of young women (≤ 40 yo) with de novo metastatic breast cancer in the multicenter national observational ESME program

P.14.11 Auto-immune necrotizing myopathies with anti-HMGCR antibodies are related to statin-exposure only for a minority of cases

P2.49 Myopathies with mutations in anoctamin 5: Phenotype and gene mutations in a French cohort

On the stability of colocated clustered finite volume simplicial discretizations for the 2D Stokes problem

Late-onset rod myopathy associated with monoclonal gammopathy

Inhibiting Effect of Vitamins C and B12 on the Mitotic Activity of Ascites Tumors

Suchergebnisse filtern